Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemiaAziz Nazha, Stefan Faderl, Hagop M. Kantarjian et al.|American Journal of Hematology|2013Cited by 53
Optimization of multi‐stage dynamic treatment regimes utilizing accumulated dataXuelin Huang, Peter F. Thall, Sangbum Choi et al.|Statistics in Medicine|2015Cited by 46
A two‐stage approach for dynamic prediction of time‐to‐event distributionsXuelin Huang, Jörge E. Cortes, Jing Ning et al.|Statistics in Medicine|2016Cited by 24
Maximum likelihood estimation of semiparametric mixture component models for competing risks dataSangbum Choi, Xuelin Huang|Biometrics|2014Cited by 16
Predicting Outcomes in Patients With Chronic Myeloid Leukemia at Any Time During Tyrosine Kinase Inhibitor TherapyAlfonso Quintás‐Cardama, Jörge E. Cortes, Sangbum Choi et al.|Clinical Lymphoma Myeloma & Leukemia|2014Cited by 16